Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,581 to 1,600 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics. | Oncogene | 2020 | 32475992 | PubTator, text mining | PubMed |
| OroxylinA reverses lipopolysaccharide-induced adhesion molecule expression and endothelial barrier disruption in the rat aorta. | Toxicol Appl Pharmacol | 2020 | 32464219 | PubTator, text mining | PubMed |
| The human genetic determinism of life-threatening infectious diseases: genetic heterogeneity and physiological homogeneity? | Hum Genet | 2020 | 32462426 | PubTator, text mining | PubMed |
| Heparanase, cell signaling, and viral infections. | Cell Mol Life Sci | 2020 | 32462405 | PubTator, text mining | PubMed |
| Immune Defect in Adults With Down Syndrome: Insights Into a Complex Issue. | Front Immunol | 2020 | 32457756 | PubTator, text mining | PubMed |
| Clinical sequelae of the novel coronavirus: does COVID-19 infection predispose patients to cancer? | Future Oncol | 2020 | 32456461 | PubTator, text mining | PubMed |
| Does NLRP3 Inflammasome and Aryl Hydrocarbon Receptor Play an Interlinked Role in Bowel Inflammation and Colitis-Associated Colorectal Cancer? | Molecules | 2020 | 32456012 | PubTator, text mining | PubMed |
| Ibrutinib Resistance Mechanisms and Treatment Strategies for B-Cell lymphomas. | Cancers (Basel) | 2020 | 32455989 | PubTator, text mining | PubMed |
| An approach using Caenorhabditis elegans screening novel targets to suppress tumour cell proliferation. | Cell Prolif | 2020 | 32452127 | PubTator, text mining | PubMed |
| Talin1 controls dendritic cell activation by regulating TLR complex assembly and signaling. | J Exp Med | 2020 | 32438408 | PubTator, text mining | PubMed |
| Platelets Endocytose Viral Particles and Are Activated via TLR (Toll-Like Receptor) Signaling. | Arterioscler Thromb Vasc Biol | 2020 | 32434410 | PubTator, text mining | PubMed |
| TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9. | Nature | 2020 | 32433612 | PubTator, text mining | PubMed |
| Assays and technologies for developing proteolysis targeting chimera degraders. | Future Med Chem | 2020 | 32431173 | PubTator, text mining | PubMed |
| Infection-induced innate antimicrobial response disorders: from signaling pathways and their modulation to selected biomarkers. | Cent Eur J Immunol | 2020 | 32425688 | PubTator, text mining | PubMed |
| Isoprenylcysteine Carboxyl Methyltransferase and Its Substrate Ras Are Critical Players Regulating TLR-Mediated Inflammatory Responses. | Cells | 2020 | 32422978 | PubTator, text mining | PubMed |
| Autoantibodies against cytokines: phenocopies of primary immunodeficiencies? | Hum Genet | 2020 | 32419033 | PubTator, text mining | PubMed |
| Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis. | Nat Rev Cancer | 2020 | 32415283 | PubTator, text mining | PubMed |
| Linear Ubiquitin Code: Its Writer, Erasers, Decoders, Inhibitors, and Implications in Disorders. | Int J Mol Sci | 2020 | 32403254 | PubTator, text mining | PubMed |
| FLT3-IRAK dual targeting: an exciting new therapeutic option guided by adaptive activation of immune response pathways. | Ann Transl Med | 2020 | 32395555 | PubTator, text mining | PubMed |
| Pancreatic cancer stroma: an update on therapeutic targeting strategies. | Nat Rev Gastroenterol Hepatol | 2020 | 32393771 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=80